07.08.2013 Views

Misrepresentation, Non-Disclosure and Breach ... - Law Commission

Misrepresentation, Non-Disclosure and Breach ... - Law Commission

Misrepresentation, Non-Disclosure and Breach ... - Law Commission

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

11.12 The figures in the model should be treated with caution. Most are based on<br />

assumptions <strong>and</strong> estimates. The figures are included to demonstrate the<br />

workings of the model, not to provide an accurate assessment of the costs of our<br />

proposed reform.<br />

Type 1 <strong>and</strong> Type 2 firms<br />

11.13 To analyse the effect of our proposals on the critical illness market, the report<br />

divides insurance companies into Type 1 or Type 2 firms. Type 1 firms are<br />

assumed to abide by FOS guidance <strong>and</strong> FSA regulations, <strong>and</strong> to have<br />

institutionalised the requirements to treat customers fairly. On the other h<strong>and</strong>,<br />

Type 2 firms are assumed to abide by the letter of the law <strong>and</strong> no more. Our<br />

reforms would therefore have little impact on Type 1 firms whereas Type 2 firms<br />

would be forced to change their practices dramatically. The model assumes most<br />

firms are Type 1, though a few are Type 2.<br />

11.14 In practice, we doubt that any insurers are either fully Type 1 or fully Type 2.<br />

Even good insurers may occasionally make mistakes <strong>and</strong> it is unlikely that any<br />

insurers ignore all FSA rules in this area. However, some insurers seem better<br />

than others, <strong>and</strong> for analytical purposes it may be helpful to simplify reality in this<br />

way. We have been told that Type 2 firms are more likely be “closed book” firms,<br />

which are no longer selling policies <strong>and</strong> do not have a br<strong>and</strong> reputation to protect.<br />

It is also possible that some smaller firms struggle to underst<strong>and</strong> what the FOS<br />

expects of them.<br />

11.15 Despite the fact that no insurers are fully Type 1 or Type 2, analysing the effect of<br />

the reforms on these two categories of firm will display a full range of the potential<br />

economic effect of our reforms. Individual insurance companies will be able to<br />

judge where they will fall within that spectrum.<br />

11.16 We ask whether the economic analysis of our reforms should look<br />

separately at firms that follow FSA rules <strong>and</strong> FOS practice (Type 1) <strong>and</strong><br />

those that follow the law (Type 2). We welcome views on the numbers <strong>and</strong><br />

type of firms that do not currently follow FOS practice.<br />

The cost of claims<br />

11.17 The model suggests that the impact of our proposals on Type 1 firms would be<br />

relatively slight. These insurers will benefit from having the rules more clearly laid<br />

out, <strong>and</strong> will be much less likely to be undercut by unscrupulous operators. For<br />

the most part, however, their claims h<strong>and</strong>ling will be unaffected. They will<br />

continue to follow the good practice expected by the FOS <strong>and</strong> codified in our<br />

proposals.<br />

266

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!